Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 18Breast 7Gynecologic 6Gastrointestinal 6Genitourinary 5Other solid neoplasm 3Dermatologic 3Other hematologic neoplasm 2Head & Neck 2Sarcoma 1Myeloid 1Lymphoid 1Endocrine 1CNS 1

Conditions

Leukemia 53Leukemia, Myeloid, Acute 33Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 27Lymphoma, Non-Hodgkin 22Myelodysplastic Syndromes 21Lymphoma, Follicular 21Lymphoma, Mantle-Cell 20Lymphoma, Large B-Cell, Diffuse 20Leukemia, Myeloid, Chronic-Phase 19Lymphoma, Large-Cell, Immunoblastic 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Hodgkin Disease 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Congenital Abnormalities 15Multiple Myeloma 14Leukemia, Myeloid, Accelerated Phase 14Neoplasms, Plasma Cell 10Blast Crisis 10Myeloproliferative Disorders 9Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Anemia, Refractory, with Excess of Blasts 8Waldenstrom Macroglobulinemia 7Recurrence 7

Interventions

Gemcitabine 3sargramostim 2pertuzumab 2binimetinib 2Trastuzumab 2Specimen Handling 2Polymerase Chain Reaction 2Paclitaxel 2Nicotine 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Counseling 2Bupropion 2Azacitidine 2vandetanib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1tanespimycin 1sapanisertib 1romidepsin 1relatlimab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1motexafin gadolinium 1motesanib diphosphate 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × sargramostim × Other hematologic neoplasm × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

NCT00003269 2011-01-10

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Scripps Health

Phase 2 Completed
20 enrolled
BreastDermatologicGynecologicLymphoidOther hematologic neoplasmThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡